PART 212—CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS
Subparts
-
A
Subpart A—General Provisions Sections 212.1–212.5 -
B
Subpart B—Personnel and Resources Section 212.10 -
C
Subpart C—Quality Assurance Section 212.20 -
D
Subpart D—Facilities and Equipment Section 212.30 -
E
Subpart E—Control of Components, Containers, and Closures Section 212.40 -
F
Subpart F—Production and Process Controls Section 212.50 -
G
Subpart G—Laboratory Controls Sections 212.60–212.61 -
H
Subpart H—Finished Drug Product Controls and Acceptance Sections 212.70–212.71 -
I
Subpart I—Packaging and Labeling Section 212.80 -
J
Subpart J—Distribution Section 212.90 -
K
Subpart K—Complaint Handling Section 212.100 -
L
Subpart L—Records Section 212.110